» Articles » PMID: 21047960

HIV-1-specific Interleukin-21+ CD4+ T Cell Responses Contribute to Durable Viral Control Through the Modulation of HIV-specific CD8+ T Cell Function

Abstract

Functional defects in cytotoxic CD8(+) T cell responses arise in chronic human viral infections, but the mechanisms involved are not well understood. In mice, CD4 cell-mediated interleukin-21 (IL-21) production is necessary for the maintenance of CD8(+) T cell function and control of persistent viral infections. To investigate the potential role of IL-21 in a chronic human viral infection, we studied the rare subset of HIV-1 controllers, who are able to spontaneously control HIV-1 replication without treatment. HIV-specific triggering of IL-21 by CD4(+) T cells was significantly enriched in these persons (P = 0.0007), while isolated loss of IL-21-secreting CD4(+) T cells was characteristic for subjects with persistent viremia and progressive disease. IL-21 responses were mediated by recognition of discrete epitopes largely in the Gag protein, and expansion of IL-21(+) CD4(+) T cells in acute infection resulted in lower viral set points (P = 0.002). Moreover, IL-21 production by CD4(+) T cells of HIV controllers enhanced perforin production by HIV-1-specific CD8(+) T cells from chronic progressors even in late stages of disease, and HIV-1-specific effector CD8(+) T cells showed an enhanced ability to efficiently inhibit viral replication in vitro after IL-21 binding. These data suggest that HIV-1-specific IL-21(+) CD4(+) T cell responses might contribute to the control of viral replication in humans and are likely to be of great importance for vaccine design.

Citing Articles

Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy.

Julg B, Stephenson K, Tomaka F, Walsh S, Tan C, Lavreys L NPJ Vaccines. 2024; 9(1):89.

PMID: 38782902 PMC: 11116546. DOI: 10.1038/s41541-024-00876-2.


The Role of CD4 T Cell Help in CD8 T Cell Differentiation and Function During Chronic Infection and Cancer.

Topchyan P, Lin S, Cui W Immune Netw. 2023; 23(5):e41.

PMID: 37970230 PMC: 10643329. DOI: 10.4110/in.2023.23.e41.


Spontaneous HIV expression during suppressive ART is associated with the magnitude and function of HIV-specific CD4 and CD8 T cells.

Dube M, Tastet O, Dufour C, Sannier G, Brassard N, Delgado G Cell Host Microbe. 2023; 31(9):1507-1522.e5.

PMID: 37708853 PMC: 10542967. DOI: 10.1016/j.chom.2023.08.006.


The Important Role of Interleukin-2 in COVID-19.

Ghanbari Naeini L, Abbasi L, Karimi F, Kokabian P, Abdi Abyaneh F, Naderi D J Immunol Res. 2023; 2023:7097329.

PMID: 37649897 PMC: 10465260. DOI: 10.1155/2023/7097329.


IL-6 and IL-27 play both distinct and redundant roles in regulating CD4 T-cell responses during chronic viral infection.

Harker J, Greene T, Barnett B, Bao P, Dolgoter A, Zuniga E Front Immunol. 2023; 14:1221562.

PMID: 37583704 PMC: 10424726. DOI: 10.3389/fimmu.2023.1221562.


References
1.
Iannello A, Boulassel M, Samarani S, Debbeche O, Tremblay C, Toma E . Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study. J Immunol. 2009; 184(1):114-26. DOI: 10.4049/jimmunol.0901967. View

2.
Alkhatib G, Combadiere C, Broder C, Feng Y, Kennedy P, Murphy P . CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 1996; 272(5270):1955-8. DOI: 10.1126/science.272.5270.1955. View

3.
Yi J, Du M, Zajac A . A vital role for interleukin-21 in the control of a chronic viral infection. Science. 2009; 324(5934):1572-6. PMC: 2736049. DOI: 10.1126/science.1175194. View

4.
Saez-Cirion A, Pancino G, Sinet M, Venet A, Lambotte O . HIV controllers: how do they tame the virus?. Trends Immunol. 2007; 28(12):532-40. DOI: 10.1016/j.it.2007.09.002. View

5.
Kaufmann D, Bailey P, Sidney J, Wagner B, Norris P, Johnston M . Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol. 2004; 78(9):4463-77. PMC: 387674. DOI: 10.1128/jvi.78.9.4463-4477.2004. View